AdaptHealth Raises 2026 EBITDA Guidance Following Strong Q3 Performance
AdaptHealth (AHCO) reported strong third-quarter results, exceeding previous guidance for both revenue and adjusted EBITDA while meeting free cash flow targets. CEO Suzanne Foster characterized the quarter as a significant step forward, driven by robust organic growth and operational improvements. The company provided an optimistic long-term outlook, raising its 2026 adjusted EBITDA guidance to a range of $510 million to $525 million. Additionally, management outlined a strategic path to achieve a 20% margin on its largest capitated contract by the fourth quarter of next year.
Tickers: $AHCO
Topics: earnings report EBITDA free cash flow organic growth
Read the full article at Seeking Alpha
Part of the story DeFi Technologies Schedules Shareholder Call for Q3 2026 Financial Results (51 articles)